Ukusetshenziswa kwama-NSAID For Pain Chronic

Ama-NSAID ajwayele ukusetshenziselwa ukwelashwa okuphulukako okungapheli

Uma ufunda ilebula yezinhlungu eziningi zokunciphisa izinhlungu, uzothola iseluleko mayelana nokuxhumana nodokotela wakho uma ubuhlungu bakho buhlala isikhathi esingaphezu kwesonto noma kunjalo. Yiqiniso, uma unesihlungu esingapheli, ubuhlungu bakho cishe buhlale izinyanga eziningi noma ngaphezulu. Lokhu akusho ukuthi izidakamizwa ezingezona ukuvuvukala (non-steroidal anti-inflammatory drugs) (NSAIDs) azifanelekile ukwelashwa okubuhlungu okungapheli .

Eqinisweni, ama-NSAID ajwayele ukusetshenziselwa ukulawula ubuhlungu obukhulu obungokomzimba nezifo zamathambo. Kungabuye kuthathwe ngaphezu kweminye imithi yobuhlungu njenge- opioids noma i- analgesics ye-adjuvant yokuphatha ubuhlungu bokuphuza .

Ama-NSAID amaningi atholakala ekuthengeni okungaphezu kwe-counter, nakuba amafomu aqinile angadinga isigwebo somdokotela. Amanye ama-NSAID atholakale kuphela emandleni kadokotela. Lezi yi-NSAID ezivame ukusetshenziswa kakhulu ngobuhlungu obungapheliyo.

Ama-NSAID angaphezu kwe-Counter for Pain Chronicle

I-NSAID ye-prescription ye-Pain Chronicle

I-NSAID Ukuphepha Nokuhlupheka Okungapheli

Wonke ama-NSAID wezinhlungu ezingapheliyo, kuhlanganise nalabo abathengiwe ngaphezulu, manje ahlanganisa izixwayiso ze-FDA ngezinkinga zabo ezingahle zibe khona. Naphezu kwalokhu, baqhubeka beyodwa yamakilasi athandwa kakhulu ezidakamizwa asetshenziselwa ukuphatha ubuhlungu obungapheli.

I-NSAID yesidakamizwa yokubuhlungu okungapheli inganconywa ukuthi isebenzise isikhathi eside uma umuntu enengozi eyengeziwe yokwehluleka kwe-GI. Laba bantu bangabandakanya abantu abadala kanye nanoma ubani onomlando wezilonda noma ezinye izinkinga zokuphuma kwegazi.

Uma uthatha ama-NSAID ngobuhlungu obungapheli, ungamangazi uma udokotela wakho ehlola njalo igazi lakho. I-NSAID enobungozi engaba khona ingagwenywa ngokuqapha kokubili inani lakho legazi namazinga akho e-creatine. Uma amazinga akho ebonakala engakaboni, udokotela wakho angashintsha imithi yakho noma anikeze izidakamizwa ezengeziwe ukulwa nanoma yiziphi izinkinga ezingase zibe khona.

Imithombo:

I-American Chronic Pain Association. Imithi ye-APCA nokuPhepha OkuPhezulu: Isongezo 2007. Ithole ngo-6/21/09. http://www.theacpa.org/documents/ACPA%20Meds%202007%20Final.pdf

I-Merck Manuals Medical Library Library. Ubuhlungu: Ukwelashwa. Ifinyelele ngo-6/21/09. http://www.merck.com/mmhe/sec06/ch078/ch078d.html

Patino FG, Olivieri J, Allison JJ, Mikuls TR, Moreland L, Kovac SH, Juarez L, Umuntu S, Curtis J, noSaag KG. Ukuqapha Ukudakwa Kokudakwa Kwezidakamizwa Nezokuphepha. Journal of Rheumatology. 2003 Dec; 30 (12): 2680-8

Ukuphathwa Kwezokudla Nezidakamizwa zase-US. I-COX-2 Ekhethiwe (ihlanganisa i-Bextra, i-Celebrex, ne-Vioxx) kanye nezidakamizwa ezingezona ezakhethiyo ezingezona ezama-anti-inflammatory drugs (NSAIDs). Ifinyelele ngo-6/21/09. http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm103420.htm